Ligand Pharmaceuticals Inc - 10%+ Owner at Channel Therapeutics Corp

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
CHRO on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ligand Pharmaceuticals Inc since 10/18/2024

Holdings reported by Ligand Pharmaceuticals Inc for Channel Therapeutics Corp

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.5M $15M $10.00 Jul 1, 2025 Direct
Series A Convertible Preferred Stock 34.3K Jul 1, 2025 Direct Common Stock

Transactions reported by Ligand Pharmaceuticals Inc for Channel Therapeutics Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.